Eledon Pharmaceuticals, Inc. (ELDN) Tops Q1 EPS by 17c

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.08), $0.17 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Burke & Herbert Bank & Trust Company (BHRB) Tops Q2 EPS by 5c
• Alpine Income Property Trust, Inc. (PINE) Tops Q2 EPS by 2c; Offers Guidance